The role of HGF-MET pathway and CCDC66 cirRNA expression in EGFR resistance and epithelial-to-mesenchymal transition of lung adenocarcinoma cells

Epidermal growth factor signals regulate dihydropyrimidine dehydrogenase expression in EGFR-mutated non-small-cell lung cancer

(2016) Tetsuro Tominaga et al.   BMC CANCER

Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal

(2016) Li Du et al.   Nature Communications

Regulation of hepatocyte growth factor expression by NF-κB and PPARγ in adipose tissue

(2014) Jun Yin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Human RAD23 homolog A is required for the nuclear translocation of apoptosis-inducing factor during induction of cell death

(2014) Janaki N. Sudhakar et al.   BIOLOGY OF THE CELL

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Sumoylation: A Regulatory Protein Modification in Health and Disease

(2013) Annette Flotho et al.   Annual Review of Biochemistry

MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling

(2013) Su Jung Song et al.   CELL

Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

(2013) Chee Khoon Lee et al.   JNCI-Journal of the National Cancer Institute

A SUMOylation-Dependent Pathway Regulates SIRT1 Transcription and Lung Cancer Metastasis

(2013) Lina Sun et al.   JNCI-Journal of the National Cancer Institute

EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2

(2013) Jia Shen et al.   NATURE

Mitochondrial protein ATPase family, AAA domain containing 3A correlates with radioresistance in glioblastoma

(2013) W.-C. You et al.   NEURO-ONCOLOGY

Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway

(2012) S Maseki et al.   BRITISH JOURNAL OF CANCER

Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells

(2011) Chih-Yi Chen et al.   CANCER SCIENCE

Sorafenib Inhibits the Hepatocyte Growth Factor-Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma

(2011) T. Nagai et al.   MOLECULAR CANCER THERAPEUTICS

A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis

(2011) J. D. Kessler et al.   SCIENCE

Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Adenocarcinoma

(2010) K. Kasahara et al.   CLINICAL CANCER RESEARCH

ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells

(2010) H.-Y. Fang et al.   JOURNAL OF CELL SCIENCE

Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations

(2010) Jenn-Yu Wu et al.   LUNG CANCER

SUMOylation of the GTPase Rac1 is required for optimal cell migration

(2010) Sonia Castillo-Lluva et al.   NATURE CELL BIOLOGY

SUMOylation and deSUMOylation at a glance

(2009) Y. Wang et al.   JOURNAL OF CELL SCIENCE

Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas

(2009) Yung-Yen Chiang et al.   MODERN PATHOLOGY

The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress

(2009) Joanna R. Morris et al.   NATURE

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations

(2008) S. Yano et al.   CANCER RESEARCH